Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

EQT, Genie Energy And Other Big Stocks Moving Lower On Monday

Author: Avi Kapoor | March 11, 2024 10:37am

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

Shares of EQT Corporation (NYSE:EQT) fell sharply during Monday’s session after the company announced that it entered into a definitive merger agreement to acquire Equitrans Midstream.

EQT shares fell 8.4% to $34.37 on Monday.

Here are some other big stocks recording losses in today’s session.

  • Ventyx Biosciences, Inc. (NASDAQ:VTYX) shares tumbled 18.5% to $8.09. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.
  • MoneyLion Inc. (NYSE:ML) dipped 15% to $63.36.
  • Genie Energy Ltd. (NYSE:GNE) declined 12% to $16.67 following fourth-quarter results.
  • Nanobiotix S.A. (NASDAQ:NBTX) dipped 9.8% to $6.35.
  • Pagaya Technologies Ltd. (NASDAQ:PGY) fell 9.6% to $16.54.
  • Bitfarms Ltd. (NASDAQ:BITF) fell 9% to $2.4290. Bitfarms purchased additional miners to reach 21 EH/s in 2024.
  • Quantum-Si incorporated (NASDAQ:QSI) declined 9% to $2.03.
  • Super Micro Computer, Inc. (NASDAQ:SMCI) dipped 8.8% to $1,039.60.
  • MannKind Corporation (NASDAQ:MNKD) dipped 8.7% to $4.81. MannKind announced initial meal challenge data from INHALE-3 Phase 4 U.S. trial comparing afrezza head-to-head with multiple daily injections and insulin pumps.
  • Applied Therapeutics, Inc. (NASDAQ:APLT) fell 8.4% to $6.35.
  • Poseida Therapeutics, Inc. (NASDAQ:PSTX) declined 8.1% to $3.74.
  • Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) fell 7.6% to $30.90. Arrowhead Pharmaceuticals recently announced that it initiated its Phase 1/2a study of ARO-DM1 for the treatment of type 1 myotonic dystrophy.
  • Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) dipped 7.6% to $10.31. Arcutis promoted Todd Tucker to Chief Human Resources Officer.
  • Carvana Co. (NYSE:CVNA) fell 6.3% to $79.96.
  • Celestica Inc. (NYSE:CLS) fell 5.7% to $43.45. Cormark Securities analyst Jesse Pytlak initiated coverage on Celestica with a Buy rating and announced a price target of $56.
  • NOVONIX Limited (NYSE:NVX) fell 5.2% to $2.37.

 

Now Read This: Top 5 Risk Off Stocks That May Plunge This Quarter

Posted In: APLT ARQT ARWR BITF CLS CVNA EQT GNE ML MNKD NBTX NVX PGY PSTX QSI SMCI VTYX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist